IL1A and graft versus host disease: Consequently, polymorphisms within the IL-1 gene—particularly the variable number of tandem repeats (VNTR) polymorphism of IL-1Ra—may be significant for donor selection and could contribute to optimizing GVHD prophylaxis and therapeutic outcomes [30].